Correlation Between Farglory FTZ and Orient Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Farglory FTZ and Orient Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Farglory FTZ and Orient Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Farglory FTZ Investment and Orient Pharma Co, you can compare the effects of market volatilities on Farglory FTZ and Orient Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Farglory FTZ with a short position of Orient Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Farglory FTZ and Orient Pharma.

Diversification Opportunities for Farglory FTZ and Orient Pharma

-0.82
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Farglory and Orient is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Farglory FTZ Investment and Orient Pharma Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orient Pharma and Farglory FTZ is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Farglory FTZ Investment are associated (or correlated) with Orient Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orient Pharma has no effect on the direction of Farglory FTZ i.e., Farglory FTZ and Orient Pharma go up and down completely randomly.

Pair Corralation between Farglory FTZ and Orient Pharma

Assuming the 90 days trading horizon Farglory FTZ Investment is expected to under-perform the Orient Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Farglory FTZ Investment is 1.12 times less risky than Orient Pharma. The stock trades about -0.01 of its potential returns per unit of risk. The Orient Pharma Co is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  2,095  in Orient Pharma Co on September 4, 2024 and sell it today you would earn a total of  1,700  from holding Orient Pharma Co or generate 81.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Farglory FTZ Investment  vs.  Orient Pharma Co

 Performance 
       Timeline  
Farglory FTZ Investment 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Farglory FTZ Investment has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Farglory FTZ is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Orient Pharma 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Orient Pharma Co are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Orient Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Farglory FTZ and Orient Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Farglory FTZ and Orient Pharma

The main advantage of trading using opposite Farglory FTZ and Orient Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Farglory FTZ position performs unexpectedly, Orient Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Pharma will offset losses from the drop in Orient Pharma's long position.
The idea behind Farglory FTZ Investment and Orient Pharma Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets